New efficient synthesis of combretastatin A-4 via Colvin rearrangement

Synthesis

Volumn , Issue 22, 2011, Pages 3711-3715

  Petrov, Ognyan I ^a   Gerova, Mariana S ^a   Chanev, Christo D ^a   Petrova, Katya V ^b  

^a UNIVERSITY OF SOFIA   (Bulgaria)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

anticancer agents; Colvin rearrangement; combretastatin A 4; phenstatin; stilbene

Indexed keywords

ANTI-CANCER AGENTS; COLVIN REARRANGEMENT; COMBRETASTATIN A-4; PHENSTATIN; STILBENE;

2 (3 HYDROXY 4 METHOXYPHENYL) 1 (3,4,5 TRIMETHOXYPHENYL)ETHYNE; 2 [3 (TERT BUTYLDIMETHYLSILYLOXY) 4 METHOXYPHENYL] 1 (3,4,5 TRIMETHOXYPHENYL)ETHYNE; 2 METHOXY 5 (3,4,5 TRIMETHOXYBENZOYL)PHENYL 2 CHLOROACETATE; [3 (TERT BUTYLDIMETHYLSILYLOXY) 4 METHOXYPHENYL](3,4,5 TRIMETHOXYPHENYL)METHANONE; BENZOPHENONE DERIVATIVE; COMBRESTATIN A 4; ERIANIN; HEXANE; METHANOL; PHENSTATIN; TOLUENE; UNCLASSIFIED DRUG; VASCULAR TARGETING AGENT;

ARTICLE; BIOTRANSFORMATION; CATALYSIS; CHEMICAL REACTION; COLVIN REARRANGEMENT; CONTROLLED STUDY; DESILYLATION; DRUG STRUCTURE; DRUG SYNTHESIS; SOLVENT EFFECT; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

EID: 80755132238     PISSN: 00397881     EISSN: 1437210X     Source Type: Journal    
DOI: 10.1055/s-0030-1260248     Document Type: Article

References (27)

1. Pettit G R., Singh S B., Hamel E, Lin C M., Alberts D S., Garcia-Kendall D, Experientia 1989 45 209
2. Lin C M., Ho H H., Pettit G R., Hamel E, Biochemistry 1989 28 6984
3. Young S L., Chaplin D J., Expert Opin. Investig. Drugs 2004 13 1171
4. Tozer G M., Prise V E., Wilson J, Locke R J., Vojnovic B, Stratford M R., Dennis M F., Chaplin D J., Cancer Res. 1999 59 1626
5. Stevenson J P., Rosen M, Sun W, Gallagher M, Haller D G., Vaughn D, Giantonio B, Zimmer R, Petros W P., Stratford M, Chaplin D, Young S L., Schnall M, ODwyer P J., J. Clin. Oncol. 2003 21 4428
6. Kanthou C, Greco O, Stratford A, Cook I, Knight R, Benzakour O, Tozer G, Am. J. Pathol. 2004 165 1401
7. Vincent L, Kermani P, Young L M., Cheng J, Zhang F, Shido K, Lam G, Vincent H B., Zhu Z, Hicklin D J., Bohlen P, Chaplin D J., May C, Rafii S, J. Clin. Investig. 2005 115 2992
8. Vitale I, Antoccia A, Cenciarelli C, Crateri P, Meschini S, Arancia G, Pisano C, Tanzarella C, Apoptosis 2007 12 155
9. Lin H L., Chiou S H., Wu C W., Lin W B., Chen L H., Yang Y P., Tsai M L., Uen Y H., Liou J P., Chi C W., J. Pharmacol. Exp. Ther. 2007 323 365
10. Petit I, Karajannis M A., Vincent L, Young L, Butler J, Hooper A T., Shido K, Steller H, Chaplin D J., Feldman E, Rafii S, Blood 2008 111 1951
11. Shen C H., Shee J J., Wu J Y., Lin Y W., Wu J D., Liu Y W., Br. J. Pharmacol. 2010 160 2008
12. Pettit G R., Singh S B., Boyd M R., Hamel E, Pettit R K., Schmidt J M., Hogan F, J. Med. Chem. 1995 38 1666
13. Gaukroger K, Hadfield J A., Hepworth L A., Lawrence N J., McGown A T., J. Org. Chem. 2001 66 8135
14. Camacho-Dávila A A., Synth. Commun. 2008 38 3823
15. Singh R, Kaur N, Synthesis 2009 2471
16. Chen Y, Zou Y, Sun H.-Y, Liu X.-K, Xiao C.-F, Sun J, He S.-J, Li J, Synthesis 2011 217
17. Fürstner A, Nikolakis K, Liebigs Ann. Chem. 1996 2107
18. Lawrence N J., Ghani F A., Hepworth L A., Hadfield J A., McGown A T., Pritchard R G., Synthesis 1999 1656
19. Giraud A, Provot O, Hamzé A, Brion J.-D, Alami M, Tetrahedron Lett. 2008 49 1107
20. Lara-Ochoa F, Espinosa-Pérez G, Tetrahedron Lett. 2007 48 7007
21. Colvin E W., Hamill B J., J. Chem. Soc., Perkin Trans. 1 1977 869
22. Miwa K, Aoyama T, Shioiri T, Synlett 1994 107
23. Wu M, Ji Q, Yang Q, Xie Y, Org. Prep. Proced. Int. 2005 37 272
24. Majumder P L., Joardar M, Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 1984 23 1040
25. Eaton P E., Carlson G R., Lee J T., J. Org. Chem. 1973 38 4071
26. Pettit G R., Toki B, Herald D L., Verdier-Pinard P, Boyd M R., Hamel E, Pettit R K., J. Med. Chem. 1998 41 1688
27. Zou Y, Xiao C.-F, Zhong R.-Q, Wei W, Huang W.-M, He S.-J, J. Chem. Res. 2008 354